PROGRAMME
Friday, March 4th 2016
| 15:30 | 16:00 |
Genetics of inhibitors. How next generation sequencing can help to better understand the inhibitor risk Chair: Elena Santagostino (Italy) |
| 16:20 | 16:40 |
Cost of inhibitor treatment. A pharmacoeconomical perspective Chair: Frits R. Rosendaal (the Netherlands) |
| 17:20 | 18:00 |
Optimal diagnosis and treatment of patients with acquired hemophilia Chair: Pier Mannuccio Mannucci (Italy) |
Saturday, March 5th 2016
| 10:20 | 11:00 |
Future NIH programmes for the prevention of inhibitors Chair: Frits R. Rosendaal (the Netherlands) |
| Discussants: David Lillicrap and Frits R. Rosendaal | ||
| 12:00 | 13:00 |
Round Table Discussion: Benefit of fewer inhibitors? A formidable issue Moderator: Flora Peyvandi |
|
Conclusive remarks F. Peyvandi and P.M.Mannucci |
||
